GENETIC MARKERS FOR PROGNOSIS OF RHEUMATOID ARTHRITIS TREATMENT EFFICACY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140037549A1
SERIAL NO

13985468

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses markers useful in predicting the responsiveness of a subject having, or at risk of developing rheumatoid arthritis (RA) to treatment with anti-TNF agents. Particularly, the present invention discloses the allelic configuration of the CD6 gene and/or the STXBP6 gene which is indicative of the degree of responsiveness to anti-TNFα treatment of RA.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COMPUGEN LTD26 HAROKMIM ST HOLON 5885849

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bazak, Lily Givatayim, IL 12 136
Edelheit-Flohr, Sarit Tel Aviv, IL 2 0
Levine, Zurit Herzlia, IL 78 1121
Levy, Ofer Moshav Mesilat Zion, IL 90 411
Pinchas, Akiva Gedera, IL 1 0
Toporik, Amir Holon, IL 69 769
Wool, Assaf Kiryat Ono, IL 16 121
Zekharya, Tomer D.N. Shimshon, IL 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation